AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule

AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule

Submitted by admin on February 12, 2024 - 11:07pm
Source: 
Fierce Pharma
News Tags: 
AbbVie
Immunogen
M&A
Headline: 
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule
snippet: 

AbbVie has closed its $10.1 billion buyout of antibody-drug conjugate specialist ImmunoGen. And the good news from an industry perspective is that the transaction closed well ahead of AbbVie's initial expectation.

Do Not Allow Advertisers to Use My Personal information